This is a Validated Antibody Database (VAD) review about human RTP801, based on 9 published articles (read how Labome selects the articles), using RTP801 antibody in all methods. It is aimed to help Labome visitors find the most suited RTP801 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RTP801 synonym: Dig2; REDD-1; REDD1; DNA damage-inducible transcript 4 protein; HIF-1 responsive protein RTP801; protein regulated in development and DNA damage response 1

Knockout validation
Proteintech Group
rabbit polyclonal
  • western blot knockout validation; mouse; fig 2
  • western blot; human; fig 1
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot knockout validation on mouse samples (fig 2) and in western blot on human samples (fig 1). F1000Res (2016) ncbi
Proteintech Group
rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot on human samples (fig 4a). Nucleic Acids Res (2018) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 5h
In order to elucidate the mechanism by which the I4895T mutation in the type 1 ryanodine receptor/Ca(2+) release channel results in disease, Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot on mouse samples at 1:1000 (fig 5h). Nat Commun (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 1a
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot on human samples at 1:500 (fig 1a). Sci Rep (2017) ncbi
rabbit polyclonal
  • western blot knockout validation; mouse; fig 2
  • western blot; human; fig 1
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot knockout validation on mouse samples (fig 2) and in western blot on human samples (fig 1). F1000Res (2016) ncbi
rabbit polyclonal
  • western blot; human
Proteintech Group RTP801 antibody (Proteintech Group, 10638-1-AP) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
rabbit polyclonal
  • western blot; human
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot on human samples . J Biol Chem (2015) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Proteintech Group RTP801 antibody (Proteintech, 10638-1-AP) was used in western blot on human samples (fig 4a). Oncogene (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200
  • western blot; human; 1:300
Proteintech Group RTP801 antibody (Proteintech Group, 10638-1-AP) was used in immunohistochemistry - paraffin section on human samples at 1:200 and in western blot on human samples at 1:300. Placenta (2014) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human
Cell Signaling Technology RTP801 antibody (Cell Signaling Technology, 2516) was used in western blot on human samples . Cell Death Differ (2011) ncbi
Articles Reviewed
  1. Liu X, Cai S, Zhang C, Liu Z, Luo J, Xing B, et al. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress. Nucleic Acids Res. 2018;46:9601-9616 pubmed publisher
  2. Lee C, Hanna A, Wang H, Dagnino Acosta A, Joshi A, Knoblauch M, et al. A chemical chaperone improves muscle function in mice with a RyR1 mutation. Nat Commun. 2017;8:14659 pubmed publisher
  3. Salsman J, Stathakis A, Parker E, Chung D, Anthes L, Koskowich K, et al. PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. Sci Rep. 2017;7:45038 pubmed publisher
  4. Grainger D, Kutzler L, Rannels S, Kimball S. Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblasts. F1000Res. 2016;5:250 pubmed publisher
  5. Wang S, Chen X, Hu J, Jiang J, Li Y, Chan Salis K, et al. ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells. Mol Cancer Ther. 2015;14:877-88 pubmed publisher
  6. Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer. J Biol Chem. 2015;290:2024-33 pubmed publisher
  7. Yang C, Matsuura K, Huang N, Robeson A, Huang B, Zhang L, et al. Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death. Oncogene. 2015;34:3264-72 pubmed publisher
  8. Wei W, Hu Y. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy. Placenta. 2014;35:732-6 pubmed publisher
  9. Huang Y, Chuang A, Hao H, Talbot C, Sen T, Trink B, et al. Phospho-?Np63? is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ. 2011;18:1220-30 pubmed publisher